Cathie Wood's Biggest Buy Last Week Was SpaceX. She Sold Almost Exactly That Much Palantir the Same Day.

ARK bought 205,031 SpaceX shares worth about $27.5M and sold 156,110 Palantir shares for about $27.2M on the same day—an even swap (~$27M in/~$27M out). The move highlights a valuation/timing “price call”: SpaceX trades near its $135 IPO price and grew Q2 revenue +92% YoY to $7.81B, while Palantir trades around 154x earnings after shares jumped 29% on results. Overall impact is modest, as it’s disclosed positioning rather than a company-level event.

Analysis

This looks more like a valuation-ranking signal than a thesis change: ARK is still fishing in the same AI pond, but it is clearly preferring exposure where upside is less fully capitalized. That matters tactically because crowded, high-multiple software names tend to react sharply to even minor disappointments, while scarce/private-market assets can keep attracting capital without immediate public-market repricing pressure.

For PLTR, the danger is not business deterioration; it is that the stock now requires repeated evidence of re-acceleration to avoid multiple compression. When a large, visible growth sponsor is trimming into strength, marginal buyers become more price-sensitive, and that can cap the stock over the next 1-3 months even if fundamentals remain excellent. NVDA is the cleaner AI beta if investors want exposure to the capex layer rather than paying peak sentiment for the app layer.

SPCX is not cheap on an absolute basis, so this is not a blanket "buy" call. The relative advantage is that its rerating path is tied more to scarcity, funding optionality, and private-market marks over 6-18 months than to quarterly EPS scrutiny. The key falsifier for the short-PLTR / long-SPCX view is a sustained PLTR beat-and-raise cycle with margin expansion; the key falsifier for SPCX is evidence that private-market demand weakens or dilution rises.

Key Decisions for Investors

• Enter a 1-3 month relative-value trade: short PLTR vs. long SPCX on a dollar-neutral basis into any PLTR strength; target a 15-25% spread move, stop if PLTR re-accelerates and widens the valuation gap further.
• If direct SPCX access is limited, buy a small strategic SPCX position only on pullbacks to prior financing marks; size it as a 6-18 month optionality sleeve because liquidity and mark risk are the main hazards.
• Shift marginal AI exposure from PLTR into NVDA over the next 3-6 months; the trade favors the pick-and-shovel beneficiary if AI capex broadens while app-layer multiples compress.
• Use PLTR call spreads rather than outright shorts if you need a hedge; high implied volatility makes defined-risk bearish expressions more attractive than naked shorting after momentum-driven runs.
• Set a hard alert on the next PLTR guidance update: if revenue growth stays above ~70% and operating margins keep expanding, cover the short immediately—the thesis is valuation, not fundamentals.